Here are four things to know:
1. Alan Hemming, MD, was hired in October 2009 to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and UC San Diego Health-La Jolla (Calif.) Moores Cancer Center.
2. UC San Diego Health officials confirmed to the publication Dr. Hemming no longer serves as surgical director of kidney and pancreas transplantation, and said he had been replaced on an interim basis by Kristin Mekeel, MD, a board-certified transplant surgeon.
3. Officials did not discuss the situation with The San Diego Union-Tribune, but said in an email it is “hard to say” when a permanent director will be appointed.
4. Dr. Hemming, who The San Diego Union-Tribune reports made $868,000 last year, told the publication June 19, “I am still on [the] faculty,” but declined to comment further. He is still listed as a provider and a faculty member on the institutions’ websites.
More articles on hospital-physician relationships:
AMA to probe how venture capitalists, PE firms are affecting physicians
Is healthcare ready for conversational artificial intelligence?
LA police search home of former USC gynecologist amid sexual misconduct allegations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
